JIN K KIM

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease ORANGE, CA NPI 1821297797

General Payments — all program years on this page

$8,815.95

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 63
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $5,558.72 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $3,937.501
Travel and Lodging $1,076.217
Food and Beverage $545.0111

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $164.954
2019 $1,570.3816
2022 $723.905
2023 $798.0019
2024 $5,558.7219

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087022166 Novartis Pharmaceuticals Corporation $33.60 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087022168 Novartis Pharmaceuticals Corporation $22.91 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092721248 Boston Scientific Corporation $22.80 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093682732 Siemens Medical Solutions USA, Inc. $36.00 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101813415 E.R. Squibb & Sons, L.L.C. $84.09 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125436145 Abbott Laboratories $46.44 09/04/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125436147 Abbott Laboratories $489.59 09/05/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125436149 Abbott Laboratories $85.81 09/04/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125436151 Abbott Laboratories $292.67 09/04/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125436153 Abbott Laboratories $106.24 09/04/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125436155 Abbott Laboratories $46.44 09/04/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125436157 Abbott Laboratories $9.02 09/04/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1138883153 Edwards Lifesciences Corporation $145.80 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138883165 Edwards Lifesciences Corporation $46.42 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138883175 Edwards Lifesciences Corporation $8.70 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138883181 Edwards Lifesciences Corporation $35.67 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138883183 Edwards Lifesciences Corporation $37.54 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138883205 Edwards Lifesciences Corporation $3,937.50 12/23/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1146862876 Philips North America LLC $71.48 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.